Type here to filter the list

Tuesday, Apr 16th
8:30 AM – 9:45 AM CT
(D1) Non-alcoholic Steatohepatitis (NASH) Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Voice
Location: 218
Faculty: Donna Cryer, JD – Global Liver Institute
Faculty: Stephanie Spence, PharmD, CSP – CareFirst BCBS
Moderator: Amy Lugo, PharmD, BCPS, BC-ADM – LoneStar Health Solutions
Drugs, Diseases, and the Managed Care Impact
Tuesday, Apr 16th
10:15 AM – 11:30 AM CT
(D2) Spotlight 75 Session: Type 1 Diabetes: A Common and Progressive Autoimmune Disease
Location: 221
Faculty: Sanjoy Dutta, PhD – JDRF
Faculty: R. Brett McQueen, PhD – Barbara Davis Center for Diabetes
Faculty: Kimber Simmon, MD, MS – Barbara Davis Center for Diabetes
Drugs, Diseases, and the Managed Care Impact
Tuesday, Apr 16th
3:15 PM – 4:30 PM CT
(D3) Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology
Location: 218
Faculty: Mark S. Box, MD – Carondelet Rheumatology
Faculty: Cassie Ramel, PharmD BCPS – Mayo Clinic
Moderator: Michelle Booth, PharmD – Magellan Rx Management a Prime Therapeutics Company
Drugs, Diseases, and the Managed Care Impact
Wednesday, Apr 17th
9:45 AM – 11:00 AM CT
(D4) Future of Cell and Gene Therapy Management: There is More Than Value Based Contracting!
Location: 218
Faculty: Andy Killpack, PharmD – Prime Therapeutics
Faculty: Yuqian Liu, PharmD – Magellan Rx Management
Moderator: Heesung Yoon, PharmD – CVS Health
Drugs, Diseases, and the Managed Care Impact
Wednesday, Apr 17th
2:45 PM – 4:00 PM CT
(D5) “Weighing In” on Glucagon-Like Peptide-1 Receptor Agonist Utilization Management Strategies and Real-World Clinical Outcomes
Location: R3
Faculty: Jennifer Cashman, PharmD – Kaiser Permanente
Faculty: Thomas Delate, PhD, MS – Kaiser Permanente
Faculty: Catherine Pham, PharmD, MPH – Kaiser Permanente
Moderator: Renee Rizzo Fleming, RPh, MBA – PRN Managed Care Consulting Services, LLC
Drugs, Diseases, and the Managed Care Impact